Estadísticas de Regulación de P-glicoproteína (P-gp) hepática e intestinal por genisteína (GNT) en un modelo in vivo. Implicancias en la tóxico-farmacología de sus sustratos
Visitas totales
| views | |
|---|---|
| Regulación de P-glicoproteína (P-gp) hepática e intestinal por genisteína (GNT) en un modelo in vivo. Implicancias en la tóxico-farmacología de sus sustratos | 95 |
Visitas totales por mes
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 1 |
| August 2024 | 0 |
| September 2024 | 1 |
| October 2024 | 4 |
| November 2024 | 4 |
Vistas principales por país
| views | |
|---|---|
| United States | 15 |
| Argentina | 12 |
| Brazil | 8 |
| Colombia | 6 |
| Mexico | 5 |
| Peru | 3 |
| Poland | 3 |
| Vietnam | 3 |
| Chile | 2 |
| Spain | 2 |
| Bolivia | 1 |
| Ecuador | 1 |
| France | 1 |
| Israel | 1 |
| Panama | 1 |
Visitas principales por ciudad
| views | |
|---|---|
| Rosario | 8 |
| Mountain View | 6 |
| Bogotá | 5 |
| Vila Velha | 5 |
| Buenos Aires | 3 |
| Dong Ket | 3 |
| Wroclaw | 3 |
| Baltimore | 2 |
| Lima | 2 |
| Marialva | 2 |
| Palo Alto | 2 |
| Santiago | 2 |
| Alicante | 1 |
| Bello | 1 |
| Fairfield | 1 |
| Jerusalem | 1 |
| Mexico | 1 |
| Puebla | 1 |
| Quito | 1 |
| Rennes | 1 |
| San Francisco | 1 |
| San Juan del Río | 1 |
| Teresina | 1 |
| Valencia | 1 |
| Wilmington | 1 |
| Xalapa | 1 |